Intrexon reported $-5899000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US USD -39945000 3.34M
Amgen AMGN:US USD 3.04B 460M
Arrowhead Research ARWR:US USD -81170000 10.86M
AstraZeneca AZN:LN USD 3.6B 404M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Gilead Sciences GILD:US USD 3.36B 808M
Immunogen IMGN:US USD -77005000 16.41M
Intrexon XON:US USD -5899000 15.79M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Macrogenics MGNX:US USD -22111000 16.82M
Mannkind MNKD:US USD -9640000 13.91M
Merk MRK:US USD 6.49B 161M
Novartis NOVN:VX USD 4.69B 34M
Peregrine Pharmaceuticals PPHM:US USD -865000 5.2M
Roche Holding ROG:VX 13.44B 2.56B
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Thermo Fisher Scientific TMO:US USD 2.6B 258M
Veracyte VCYT:US USD -3356000 2.42M
Xencor XNCR:US USD -36110000 10.33M
YTE INCY:US USD 134.94M 141.85M